Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity.
Andrea M GrossBrittany GlassbergPamela L WoltersEva DombiAndrea BaldwinMichael J FisherAe Rang KimMiriam BornhorstBrian D WeissJaishri O BlakelyPatricia WhitcombScott M PaulSeth M SteinbergDavid J VenzonStaci MartinAmanda CarbonellKara HeiseyJanet TherrienOxana KapustinaAnne DufekJoanne DerdakMalcolm A SmithBrigitte C WidemannPublished in: Neuro-oncology (2022)
ClinicalTrials.gov NCT01362803.